Therefore, the purpose of this study was to explore the relationship between the SHR (calculating using RBG and FBG) and the clinical outcomes after thrombolytic therapy with r-tPA for patients with AIS. This evidence concerns the gene PLAT and androgen insensitivity syndrome.